Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2011The Journal of Clinical Endocrinology & Metabolism

High Prevalence of RAS Mutations in RET -Negative Sporadic Medullary Thyroid Carcinomas

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMargarida M. MouraInstituto Português de Oncologia de Coimbra Francisco GentilBCBranca CavacoUniversity of LisbonAPAntónio E. PintoNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moura et al. (2011) studied this question.

synapsesocial.com/papers/6a759e5372aedb66d66a34eahttps://doi.org/10.1210/jc.2010-1921
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas2009 · 178 citations
  2. 2Molecular Profile and Clinical-Pathologic Features of the Follicular Variant of Papillary Thyroid Carcinoma: An Unusually High Prevalence of ras Mutations2003 · 373 citations
  3. 3Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study2007 · 532 citations
  4. 4Novel Point Mutations and Allele Loss at the RET Locus in Sporadic Medullary Thyroid Carcinomas1998 · 45 citations
  5. 5RET Proto-Oncogene in the Development of Human Cancer1999 · 339 citations